Health Invest Partners Ab Portfolio Holdings

Health Invest Partners Ab

  • $206 Million
  • Q3 2024

Health Invest Partners Ab has filed its 13F form on November 12, 2024 for Q3 2024 where it was disclosed a total value porftolio of $206 Million distributed in 36 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $27.1M, Unitedhealth Group Inc with a value of $20.8M, Merck & Co., Inc. with a value of $17.6M, Thermo Fisher Scientific Inc. with a value of $13.6M, and Amgen Inc with a value of $9.33M.

Examining the 13F form we can see an increase of $46.6M in the current position value, from $160M to 206M.

Below you can find more details about Health Invest Partners Ab portfolio as well as his latest detailed transactions.

Portfolio value $206 Million
Healthcare: $206 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 36
  • Current Value $206 Million
  • Prior Value $160 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 12, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 3 stocks
  • Additional Purchases 28 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Health Invest Partners Ab Portfolio

Follow Health Invest Partners Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email